Pharmacist's Letter Canada

Commentary: Glitazones and the Risk of Bladder Cancer October 2012

Article: you'll hear MORE controversy about using pioglitazone (Actos, etc) for type 2 diabetes October 2012

Article: how to handle drug-induced edema November 2011

Article: whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients February 2011

Commentary: Restricted Use of Rosiglitazone Products (Avandia, Avandamet, and Avandaryl) December 2010

Article: Patients will be asking what to do now that rosiglitazone (Avandia, etc) use is being restricted December 2010

Other: See new Health Canada information concerning the restricted use of Avandia August 2010

Commentary: Eplerenone (Inspra) for Mild Systolic Heart Failure August 2010

Guideline: Diagnosis and Management of Heart Failure in Adults (ACC/AHA, 2009 Update) August 2010

Commentary: Cardiovascular Safety of Rosiglitazone (Avandia) – 2010 Update August 2010

Patient Education: Avandia and Risk of Heart Attack August 2010

Article: whether Avandia is riskier than Actos August 2010

Article: aldosterone antagonists (spironolactone, eplerenone) for systolic heart failure August 2010

Article: whether it's okay to give beta-blockers to patients with chronic obstructive pulmonary disease (COPD) July 2010

Commentary: Iron Replacement in Heart Failure June 2010